Catalyst Wire Dossier Catalyst Wire Dossier

Kemstro

baclofen · UCB Pharma
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Kemstro, covering 2013-08-30 to 2013-08-30. Get the full timeline:

Most recent: Clinical Trial Update: A Multicenter, Open-label Randomized Crossover Trial to Assess Subject Preference for Kemstro™ Compared to Conventional Baclofen Tablets in Subjects With Stable Multiple Sclerosis [Phase 3]

See pricing